NanoString debuts products to push COVID-19 research

By The Science Advisory Board staff writers

June 17, 2020 -- NanoString Technologies has debuted new products that advance COVID-19 research by studying the immune response of the SARS-CoV-2 virus.

The company's nCounter host response gene expression panel and COVID-19 panel plus spike-in provide comprehensive analyses of the viral infection and immune response. New protein and RNA content available on the GeoMx digital spatial profiler enables analysis of key biological pathways mapped to specific regions within infected tissues, according to NanoString.

The company demonstrated at the LabRoots Coronavirus Virtual Conference on June 17 that applying these new tools in SARS-CoV-2 formalin-fixed paraffin-embedded (FFPE) tissue samples helped better understand the processes underlying infection, pathogenesis, and therapeutic response.


Copyright © 2020 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.